Despite causing serious symptoms and having available treatments, Lambert-Eaton myasthenic syndrome (LEMS) may be frequently missed in people with lung cancer, a new study suggests. While previous studies have suggested that about 3% to 6% of people with small cell lung cancer (SCLC) develop LEMS, this claims analysis found…